NCT06574646View on ClinicalTrials.gov

Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+

NANot yet recruitingINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

August 1, 2026

Conditions

Cataract

Interventions

DEVICE

LAL+

LAL+ IOL allows for refractive error (both sphere and cylinder) enhancements post-IOL implantation by exposing the IOL to ultraviolet (UV) light through a series of noninvasive treatments with a Light Delivery Device.

DEVICE

Clareon Vivity Toric IOL

Clareon Vivity Toric IOL utilizes an extended depth of focus (EDOF) design, which incorporates nondiffractive wavefront shaping (X-WAVE) technology.

Trial Locations (1)

34209

The Eye Associates of Manatee, LLP, Bradenton

All Listed Sponsors

lead

The Eye Associates

OTHER

NCT06574646 - Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+ | Biotech Hunter | Biotech Hunter